Raymond James Financial Services Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $17.7M | Buy |
38,044
+2,323
| +7% | +$1.08M | 0.02% | 592 |
|
|
2024
Q2 | $16.7M | Buy |
35,721
+5,824
| +19% | +$2.73M | 0.02% | 581 |
|
|
2024
Q1 | $12.5M | Buy |
29,897
+3,999
| +15% | +$1.67M | 0.02% | 704 |
|
|
2023
Q4 | $10.5M | Buy |
25,898
+968
| +4% | +$394K | 0.02% | 730 |
|
|
2023
Q3 | $8.67M | Sell |
24,930
-737
| -3% | -$256K | 0.02% | 760 |
|
|
2023
Q2 | $9.03M | Buy |
25,667
+648
| +3% | +$228K | 0.02% | 749 |
|
|
2023
Q1 | $7.88M | Sell |
25,019
-4,257
| -15% | -$1.34M | 0.01% | 789 |
|
|
2022
Q4 | $8.45M | Buy |
29,276
+6,273
| +27% | +$1.81M | 0.02% | 725 |
|
|
2022
Q3 | $6.66M | Sell |
23,003
-3,290
| -13% | -$953K | 0.01% | 790 |
|
|
2022
Q2 | $7.41M | Sell |
26,293
-283
| -1% | -$79.7K | 0.02% | 746 |
|
|
2022
Q1 | $6.94M | Buy |
26,576
+1,221
| +5% | +$319K | 0.01% | 843 |
|
|
2021
Q4 | $5.57M | Buy |
25,355
+742
| +3% | +$163K | 0.01% | 963 |
|
|
2021
Q3 | $4.47M | Buy |
24,613
+4,047
| +20% | +$734K | 0.01% | 1041 |
|
|
2021
Q2 | $4.15M | Buy |
20,566
+2,619
| +15% | +$528K | 0.01% | 1064 |
|
|
2021
Q1 | $3.86M | Sell |
17,947
-10,040
| -36% | -$2.16M | 0.01% | 1027 |
|
|
2020
Q4 | $6.61M | Buy |
27,987
+7,734
| +38% | +$1.83M | 0.02% | 711 |
|
|
2020
Q3 | $5.51M | Sell |
20,253
-13,614
| -40% | -$3.7M | 0.02% | 715 |
|
|
2020
Q2 | $9.83M | Buy |
+33,867
| New | +$9.83M | 0.03% | 461 |
|
|
2020
Q1 | – | Sell |
-10,807
| Closed | -$2.37M | – | 2810 |
|
|
2019
Q4 | $2.37M | Sell |
10,807
-1,039
| -9% | -$227K | 0.01% | 1088 |
|
|
2019
Q3 | $2.01M | Sell |
11,846
-17,901
| -60% | -$3.03M | 0.01% | 1106 |
|
|
2019
Q2 | $5.46M | Sell |
29,747
-910
| -3% | -$167K | 0.02% | 649 |
|
|
2019
Q1 | $5.64M | Buy |
30,657
+4,688
| +18% | +$862K | 0.02% | 606 |
|
|
2018
Q4 | $4.3M | Sell |
25,969
-8,978
| -26% | -$1.49M | 0.02% | 589 |
|
|
2018
Q3 | $6.74M | Buy |
34,947
+1,567
| +5% | +$302K | 0.03% | 533 |
|
|
2018
Q2 | $5.67M | Buy |
33,380
+986
| +3% | +$168K | 0.03% | 552 |
|
|
2018
Q1 | $5.28M | Buy |
32,394
+13,681
| +73% | +$2.23M | 0.03% | 528 |
|
|
2017
Q4 | $2.8M | Sell |
18,713
-9,643
| -34% | -$1.44M | 0.02% | 764 |
|
|
2017
Q3 | $4.31M | Buy |
28,356
+21,887
| +338% | +$3.33M | 0.03% | 577 |
|
|
2017
Q2 | $834K | Buy |
6,469
+1,397
| +28% | +$180K | 0.01% | 1377 |
|
|
2017
Q1 | $555K | Sell |
5,072
-357
| -7% | -$39.1K | ﹤0.01% | 1504 |
|
|
2016
Q4 | $400K | Sell |
5,429
-3,854
| -42% | -$284K | ﹤0.01% | 1650 |
|
|
2016
Q3 | $810K | Buy |
9,283
+3,751
| +68% | +$327K | 0.01% | 1214 |
|
|
2016
Q2 | $476K | Buy |
5,532
+25
| +0.5% | +$2.15K | ﹤0.01% | 1451 |
|
|
2016
Q1 | $438K | Buy |
+5,507
| New | +$438K | 0.01% | 1330 |
|